Dr. John Edwin Trusheim, MD

Dr. Trusheim practices at Noran Neurological Clinic P.A. in Minneapolis, Minnesota.

Dr. Trusheim's NPI, 1689600595, was assigned on June 23, 2006. Dr. Trusheim graduated from University of Missouri, Columbia School of Medicine in 1980. Dr. Trusheim holds Minnesota license 30535.

Dr. Trusheim's primary practice is Noran Neurological Clinic P.A., at 3601 Minnesota Dr, Minneapolis, MN 55435 in Hennepin County. The practice phone is (612) 879-1000.

Dr. Trusheim's primary practice is Noran Neurological Clinic P.A. in Minneapolis, Minnesota. The medical group on file is Noran Neurology. Dmand AI also links Dr. Trusheim to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trusheim practices. Vendor and product names are available with a free account.

Neurology is Dr. Trusheim's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Trusheim is licensed in Minnesota.

CMS data shows 127 Medicare services from Dr. Trusheim across 4 procedure codes in 2024, all of them office visits, for 89 Medicare patients. Medicare paid $12,204 for them. Every service was in an office.

CMS counts 89 Medicare patients who saw Dr. Trusheim in 2024. The largest group is 75 to 84, with 31 patients. 65% of them have high blood pressure, and 52% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Trusheim's median patient age at 62, with 62% women.

In 2024, Dr. Trusheim wrote 436 Medicare Part D claims for 117 patients. 99% of them were for generic drugs. CMS names the drug for 352 of them, across 9 drugs with 11 or more claims each, at $10,155 in total drug cost. In 2023, CMS named 240 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Trusheim for performance year 2024, reported as part of a group. Dr. Trusheim accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Trusheim, published from 2016 to 2018. 2018 was the busiest year, with 2. The most frequent topics are Brain Neoplasms, Glioblastoma and Temozolomide. Dr. Trusheim's most frequent co-authors are Fabio Massaiti Iwamoto, MD, Steven R. Abram, MD and Robert Dennis Aiken, MD.

Dmand AI links Dr. Trusheim to 6 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Brain Neoplasms.

CMS Open Payments shows 33 general payments to Dr. Trusheim from 1 drug or device company from 2016 to 2022. Honoraria make up the largest share, 44% of the total. Novocure Inc. paid the most, $5,670.

Dr. Trusheim graduated from University of Missouri, Columbia School of Medicine in 1980.